Berberine Phytosome Finally Fixes the Absorption Problem, but the Long-Term Data Hasn't Caught Up
Standard berberine is one of the most poorly absorbed supplements people actually spend money on. Berberine phytosome, a phospholipid complex designed to solve that problem, delivers roughly 10 times more berberine into the bloodstream than plain berberine in healthy humans, with no additional side effects. That's a meaningful pharmacokinetic leap, and the early clinical trials using this formulation show real metabolic improvements in the short term. The catch: human data still max out at about three months, and the conditions studied so far are narrow. So you're looking at a supplement with a genuinely better delivery system and promising early results, but without the long-term evidence to match the enthusiasm surrounding it.